Results 101 to 110 of about 819 (177)

Self‐Assembly of Therapeutic Peptides for Enhanced Cancer Therapy: Strategies, Therapeutic Performance, and Future Perspectives

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.
Therapeutic peptide self‐assembly is governed by multiple non‐covalent interactions, enabling the construction of diverse supramolecular structures. These self‐assembled systems can be engineered through spontaneous self‐assembly of monomers, co‐assembly, or stimulus‐responsive strategies to improve tumor delivery efficiency.
Yuelin Fang   +6 more
wiley   +1 more source

LLM‐Guided Parameter Optimization for Mechanistic CHO Cell Bioreactor Models

open access: yesBiotechnology and Bioengineering, Volume 123, Issue 11, Page 3175-3182, November 2026.
ABSTRACT Mechanistic models of Chinese Hamster Ovary (CHO) cell cultures are essential for efficient bioprocess development and control, yet parameter estimation remains a critical challenge in model calibration. As model complexity increases, the number of parameters grows and their values become highly system‐specific due to biological variability ...
Han Bit Kim   +4 more
wiley   +1 more source

Hesperidin as a Multi‐Target Phytochemical: Therapeutic Applications, Medicinal Chemistry Insights, and Advances in Synthetic Analogs

open access: yesFood Frontiers, Volume 7, Issue 6, November 2026.
This review offers a thorough examination of the therapeutic uses of hesperidin, emphasizes significant findings from structure‐activity relationship research, and addresses recent advancements in the synthesis and biological assessment of hesperidin analogs.
Mohammadsaeed Kordi   +5 more
wiley   +1 more source

PEGylated Chrysin: In Vitro Biological Activity and Mechanistic Insights in HepG2 Cells

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 11, November 2026.
PEGylated chrysin exhibited antiproliferative effects in HepG2 cells, inducing apoptosis, membrane damage, genotoxicity, and wound closure. Compared to paclitaxel, it caused lower ROS production and overall cytotoxicity, while efficiently accumulating in the cytoplasm, supporting its potential as a liver cancer therapeutic candidate. ABSTRACT PEGylated
Fátima Belén Gasser   +9 more
wiley   +1 more source

Microfluidic Profiling of an Immune Cell‐Associated Extracellular Vesicle Signature for Active Tuberculosis Diagnosis and Treatment Monitoring

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 11, November 2026.
Integrating microfluidic parallel detection with an innate immune extracellular vesicle signature enables rapid active tuberculosis diagnosis from 10 µL of plasma in 30 minutes, effectively discriminating non‐tuberculous respiratory diseases and monitoring treatment response.
Eun Ju Lee   +12 more
wiley   +1 more source

Physiologically Based Biopharmaceutics Modeling (PBBM) to Evaluate the Biopredictive Power of Dissolution Methods for Rivaroxaban Tablets

open access: yes
The aim of this study was to use the physiologically based biopharmaceutics modeling (PBBM) strategy to evaluate the biopredictive power of different dissolution test conditions for immediate release tablets containing 20 mg of rivaroxaban. The model was developed and validated with literature data and used to predict plasma concentration-time curves ...
Eduardo Nabais de Carvalho Lauro   +4 more
openaire   +1 more source

Polyomavirus Drives Cerebellar Lesions in AIDS Monkeys With Ataxia

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Chronic SIV‐infected macaques with ataxia develop severe cerebellar lesions driven by simian polyomavirus 40 (SV40) infection. SV40 preferentially infects cerebellar granule cells, inducing pyroptosis and an aberrant proliferative state. Pyroptotic neuronal injury promotes microglial recruitment and activation, amplifying local neuroinflammation and ...
Tian‐Zhang Song   +9 more
wiley   +1 more source

Target‐Engagement Prediction From Molecular Structure, In Vitro and Animal Data: A Tutorial for Early Assessment of Clinical Drug Exposure and Therapeutic/Adverse Potential Using the ANDROMEDA and PLATO Software on the InSilicoTrials Platform

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 11, November 2026.
ABSTRACT The target‐engagement predictor, implemented within the InSilicoTrials cloud‐based, AI‐powered platform for model‐informed drug discovery and development, enables early exploration of time‐dependent pharmacological responses. Predictions can be generated using inputs ranging from molecular structure to in vitro, animal, and clinical data ...
Niccolò Totis   +16 more
wiley   +1 more source

Drug–Drug Interactions of Cenobamate With Medications: Dose‐Dependent Induction/Inhibition and Clinical Implications

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 11, November 2026.
ABSTRACT Cenobamate causes dose‐dependent cytochrome P450 (CYP)2B6 and CYP3A4 induction and CYP2C19 inhibition, raising concern over multi‐pathway drug–drug interactions (DDIs) in patients with epilepsy treated with cardiovascular co‐medications. We developed a physiologically based pharmacokinetic (PBPK) model for cenobamate and verified it using ...
Hiroyuki Ichida   +7 more
wiley   +1 more source

Breaking Alzheimer's Disease Barrier: The Role of Xanthoceras sorbifolia Bunge Oil in Gut‐Brain Axis and TLR4/Myd88/MAPK Pathway Inhibition

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6216-6232, November 2026.
ABSTRACT Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with cognitive decline and neuroinflammation. Xanthoceras sorbifolia Bunge oil (XSBO), a woody plant oil rich in bioactive fatty acids, has shown potential health benefits.
Lijing Du   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy